CRTX Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 | Monohon Ted | officer: Chief Accounting Officer & VP | 250,000 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2022-06-09 | Bray June | director: | 54,000 | A-Award | A | 54,000 | 0.00 | 0.00 |
| 2022-06-09 | Bray June | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-06-08 | Senner Christopher J. | director: | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
| 2022-06-08 | RYAN UNA S | director: | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
| 2022-06-08 | RYAN UNA S | director | 27,000 | A-Award | A | 27,000 | 3.23 | 87,210.00 |
| 2022-06-08 | Lamond David | director: | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
| 2022-06-08 | Lamond David | director | 27,000 | A-Award | A | 27,000 | 3.23 | 87,210.00 |
| 2022-06-08 | McLoughlin Margaret | director: | 27,000 | A-Award | A | 27,000 | 0.00 | 0.00 |
| 2022-06-08 | McLoughlin Margaret | director | 27,000 | A-Award | A | 27,000 | 3.23 | 87,210.00 |
| 2022-06-06 | Monohon Ted | officer: Chief Accounting Officer & VP | 32,471 | F-InKind | D | 1,529 | 3.12 | 4,770.00 |
| 2022-06-06 | Holsinger Leslie | officer: EVP, Preclinical Development | 148,080 | F-InKind | D | 10,920 | 2.86 | 31,231.00 |
| 2022-06-06 | McDowell Caryn Gordon | officer: Chief Legal & Adm. Officer | 133,300 | F-InKind | D | 6,700 | 2.86 | 19,183.00 |
| 2022-06-06 | McDowell Caryn Gordon | officer: Chief Legal & Adm. Officer | 122,500 | S-Sale | D | 10,800 | 2.86 | 30,923.00 |
| 2022-05-19 | Smith Karen L. | officer: Chief Medical Officer | 194,690 | A-Award | A | 170,354 | 0.00 | 0.00 |
| 2022-05-19 | Thye Dirk | director, officer: Chief Executive Officer | 280,911 | A-Award | A | 216,322 | 0.00 | 0.00 |
| 2022-05-19 | Hannah Brendan | officer: Chief Business Officer | 129,793 | A-Award | A | 113,569 | 0.00 | 0.00 |
| 2022-05-19 | Thye Dirk | officer: Chief Executive Officer | 64,589 | A-Award | A | 64,589 | 0.00 | 0.00 |
| 2022-05-19 | Thye Dirk | director, officer: Chief Executive Officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-19 | Smith Karen L. | officer: Chief Medical Officer | 1,365,449 | A-Award | A | 1,365,449 | 0.00 | 0.00 |
| 2022-05-19 | Smith Karen L. | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-19 | Low Philip S | director: | 22,058 | A-Award | A | 22,058 | 0.00 | 0.00 |
| 2022-05-19 | Low Philip S | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-19 | Lamond David | director: | 1,734,722 | A-Award | A | 200,002 | 0.00 | 0.00 |
| 2022-05-19 | Hannah Brendan | officer: Chief Business Officer | 353,656 | A-Award | A | 353,656 | 0.00 | 0.00 |
| 2022-05-19 | Hannah Brendan | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-03-14 | Sabbagh Marwan | director: | 22,058 | A-Award | A | 22,058 | 0.00 | 0.00 |
| 2022-03-14 | Sabbagh Marwan | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-03-03 | Monohon Ted | officer: Chief Accounting Officer & VP | 34,000 | A-Award | A | 34,000 | 0.00 | 0.00 |
| 2022-03-03 | McDowell Caryn Gordon | officer: Chief Legal & Adm. Officer | 140,000 | A-Award | A | 140,000 | 0.00 | 0.00 |
| 2022-03-03 | LOWE CHRISTOPHER P. | officer: Interim CEO, COO & CFO | 265,000 | A-Award | A | 175,000 | 0.00 | 0.00 |
| 2022-03-03 | Holsinger Leslie | officer: EVP, Preclinical Development | 159,000 | A-Award | A | 155,500 | 0.00 | 0.00 |
| 2022-03-03 | Detke Michael J. | officer: Chief Medical Officer | 140,000 | A-Award | A | 140,000 | 0.00 | 0.00 |
| 2022-01-03 | Lynch Casey | director, officer: Chief Executive Officer | 440,000 | A-Award | A | 440,000 | 13.39 | 5,891,600.00 |
| 2022-01-03 | McDowell Caryn Gordon | officer: Chief Legal & Adm. Officer | 125,000 | A-Award | A | 125,000 | 13.39 | 1,673,750.00 |
| 2022-01-03 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 125,000 | A-Award | A | 125,000 | 13.39 | 1,673,750.00 |
| 2022-01-03 | Holsinger Leslie | officer: EVP, R&D | 125,000 | A-Award | A | 125,000 | 13.39 | 1,673,750.00 |
| 2022-01-03 | Dominy Stephen S. | director, officer: Chief Scientific Officer | 125,000 | A-Award | A | 125,000 | 13.39 | 1,673,750.00 |
| 2022-01-03 | Detke Michael J. | officer: Chief Medical Officer | 125,000 | A-Award | A | 125,000 | 13.39 | 1,673,750.00 |
| 2021-12-14 | Monohon Ted | officer: Chief Accounting Officer | 50,000 | A-Award | A | 50,000 | 11.35 | 567,500.00 |
| 2021-11-18 | Lynch Casey | director, officer: Chief Executive Officer | 109,895 | M-Exempt | A | 60,000 | 0.46 | 27,600.00 |
| 2021-11-18 | Lynch Casey | director, officer: Chief Executive Officer | 23,159 | M-Exempt | D | 60,000 | 0.46 | 27,600.00 |
| 2021-11-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 103,294 | M-Exempt | D | 30,000 | 2.23 | 66,900.00 |
| 2021-11-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 90,000 | M-Exempt | A | 30,000 | 2.23 | 66,900.00 |
| 2021-11-12 | Dominy Stephen S. | director, officer: Chief Scientific Officer | 1,217,086 | P-Purchase | A | 763 | 14.40 | 10,987.00 |
| 2021-10-08 | McLoughlin Margaret | director | 84,911 | M-Exempt | D | 1,000 | 17.00 | 17,000.00 |
| 2021-10-08 | McLoughlin Margaret | director | 1,000 | M-Exempt | A | 1,000 | 17.00 | 17,000.00 |
| 2021-10-08 | McLoughlin Margaret | director | 0 | S-Sale | D | 1,000 | 88.93 | 88,930.00 |
| 2021-10-05 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 95,037 | M-Exempt | D | 4,963 | 54.85 | 272,221.00 |
| 2021-10-05 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 64,963 | M-Exempt | A | 4,963 | 54.85 | 272,221.00 |
| 2021-10-05 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 60,000 | S-Sale | D | 4,963 | 98.50 | 488,856.00 |
| 2021-08-16 | McLoughlin Margaret | director | 85,911 | M-Exempt | D | 6,000 | 17.00 | 102,000.00 |
| 2021-08-16 | McLoughlin Margaret | director | 6,000 | M-Exempt | A | 6,000 | 17.00 | 102,000.00 |
| 2021-08-16 | McLoughlin Margaret | director | 2,944 | S-Sale | D | 3,056 | 94.55 | 288,945.00 |
| 2021-08-16 | McLoughlin Margaret | director | 1,900 | S-Sale | D | 1,044 | 95.57 | 99,775.00 |
| 2021-08-16 | McLoughlin Margaret | director | 471 | S-Sale | D | 1,429 | 96.51 | 137,913.00 |
| 2021-08-16 | McLoughlin Margaret | director | 48 | S-Sale | D | 423 | 97.55 | 41,264.00 |
| 2021-08-16 | McLoughlin Margaret | director | 0 | S-Sale | D | 48 | 98.90 | 4,747.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 163,294 | M-Exempt | D | 22,000 | 2.23 | 49,060.00 |
| 2021-08-17 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 133,294 | M-Exempt | D | 30,000 | 2.23 | 66,900.00 |
| 2021-08-17 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 60,000 | M-Exempt | A | 30,000 | 2.23 | 66,900.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 52,000 | M-Exempt | A | 22,000 | 2.23 | 49,060.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 42,842 | S-Sale | D | 9,158 | 94.23 | 862,958.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 35,507 | S-Sale | D | 7,335 | 95.02 | 696,972.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 33,177 | S-Sale | D | 2,330 | 96.32 | 224,426.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 32,077 | S-Sale | D | 1,100 | 97.28 | 107,008.00 |
| 2021-08-16 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 30,000 | S-Sale | D | 2,077 | 98.90 | 205,415.00 |
| 2021-08-10 | Detke Michael J. | officer: Chief Medical Officer | 92,352 | M-Exempt | D | 10,000 | 2.23 | 22,300.00 |
| 2021-08-10 | Detke Michael J. | officer: Chief Medical Officer | 10,000 | M-Exempt | A | 10,000 | 2.23 | 22,300.00 |
| 2021-08-10 | Detke Michael J. | officer: Chief Medical Officer | 0 | S-Sale | D | 10,000 | 100.00 | 1,000,000.00 |
| 2021-07-06 | Detke Michael J. | officer: Chief Medical Officer | 119,752 | M-Exempt | D | 12,600 | 2.23 | 28,098.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 102,352 | M-Exempt | D | 17,400 | 2.23 | 38,802.00 |
| 2021-07-06 | Detke Michael J. | officer: Chief Medical Officer | 40,861 | M-Exempt | A | 12,600 | 2.23 | 28,098.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 17,400 | M-Exempt | A | 17,400 | 2.23 | 38,802.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 13,466 | S-Sale | D | 3,934 | 53.24 | 209,446.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 11,818 | S-Sale | D | 1,648 | 54.37 | 89,602.00 |
| 2021-07-06 | Detke Michael J. | officer: Chief Medical Officer | 8,548 | S-Sale | D | 32,313 | 53.43 | 1,726,484.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 7,465 | S-Sale | D | 4,353 | 55.38 | 241,069.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 523 | S-Sale | D | 6,942 | 56.27 | 390,626.00 |
| 2021-07-06 | Detke Michael J. | officer: Chief Medical Officer | 288 | S-Sale | D | 8,260 | 53.91 | 445,297.00 |
| 2021-07-07 | Detke Michael J. | officer: Chief Medical Officer | 0 | S-Sale | D | 523 | 56.99 | 29,806.00 |
| 2021-07-06 | Detke Michael J. | officer: Chief Medical Officer | 0 | S-Sale | D | 288 | 55.01 | 15,843.00 |
| 2021-06-28 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 215,594 | M-Exempt | D | 20,000 | 2.23 | 44,600.00 |
| 2021-06-30 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 185,294 | M-Exempt | D | 30,000 | 2.23 | 66,900.00 |
| 2021-06-30 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 30,000 | M-Exempt | A | 30,000 | 2.23 | 66,900.00 |
| 2021-06-28 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 20,000 | M-Exempt | A | 20,000 | 2.23 | 44,600.00 |
| 2021-06-28 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 12,276 | S-Sale | D | 7,724 | 53.39 | 412,384.00 |
| 2021-06-28 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 5,197 | S-Sale | D | 7,079 | 54.13 | 383,186.00 |
| 2021-06-28 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 1,044 | S-Sale | D | 4,153 | 55.11 | 228,872.00 |
| 2021-06-28 | LOWE CHRISTOPHER P. | officer: COO & Chief Financial Officer | 0 | S-Sale | D | 1,044 | 56.16 | 58,631.00 |
| 2021-06-28 | McLoughlin Margaret | director | 350 | S-Sale | D | 200 | 55.01 | 11,002.00 |
| 2021-06-28 | McLoughlin Margaret | director | 100 | S-Sale | D | 250 | 55.03 | 13,758.00 |
| 2021-06-28 | McLoughlin Margaret | director | 0 | S-Sale | D | 100 | 55.73 | 5,573.00 |
| 2021-06-16 | Senner Christopher J. | director | 11,029 | A-Award | A | 11,029 | 50.56 | 557,626.00 |
| 2021-06-16 | RYAN UNA S | director | 11,029 | A-Award | A | 11,029 | 50.56 | 557,626.00 |
| 2021-06-16 | McLoughlin Margaret | director | 11,029 | A-Award | A | 11,029 | 50.56 | 557,626.00 |
| 2021-06-16 | Lamond David | director | 11,029 | A-Award | A | 11,029 | 50.56 | 557,626.00 |
| 2021-05-10 | Lynch Casey | director, officer: Chief Executive Officer | 995,190 | S-Sale | D | 13,584 | 33.75 | 458,460.00 |
| 2021-05-10 | Lynch Casey | director, officer: Chief Executive Officer | 985,272 | S-Sale | D | 9,918 | 34.89 | 346,039.00 |
| 2021-05-10 | Lynch Casey | director, officer: Chief Executive Officer | 978,957 | S-Sale | D | 6,315 | 35.81 | 226,140.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
